Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01875770 · ClinicalTrials.gov registry record
Continuing Assessment of Patients Treated With ranibizUmab for REtinal Vein Occlusion (CAPTURE)
A clinical trial, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- 47
- Enrollment target
NCT01875770: Clinical Trial study, sponsored by Johns Hopkins University.
NCT01875770 is a clinical trial that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 47 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01875770 was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- 47 participants
- Enrollment target
Study Summary
This research is being done to assess the long term prognosis of patients treated with ranibizumab for edema due to retinal vein occlusion.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2013-01 |
| Est. Completion | 2021-03-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01875770
The ClinicalTrials.gov registry entry for NCT01875770 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01875770 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01875770 about?
NCT01875770 is a clinical study titled "Continuing Assessment of Patients Treated With ranibizUmab for REtinal Vein Occlusion (CAPTURE)". This research is being done to assess the long term prognosis of patients treated with ranibizumab for edema due to retinal vein occlusion.
What is the current status of trial NCT01875770?
This trial is currently terminated. The enrollment target is 47 participants. The study started on 2013-01. Estimated completion is 2021-03-03.
Who is sponsoring clinical trial NCT01875770?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.